Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

How did AstraZeneca make the Pfizer bid a Harry vs. Voldemort story?

19.05.2014 / Fierce Pharma

Analysts have pointed out the change from "significantly undervalues" to "undervalues," and the absence of the word "unanimous" from the AstraZeneca board's official rebuff of Pfizer's latest offer. The media is polling top AstraZeneca shareholders, looking for hints about which might push for deal–and how hard.

Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: